Kyowa Hakko Kirin’s Neulasta meeting better health insurance benefits

Published: 2018-04-03 16:22:48

Updated: 2018-04-03 16:22:48

The health insurance standards of Kyowa Hakko Kirin Korea’s Neulasta Prefilled Syringe(generic name: pegfilgrastim) has been partially extensively applied since 1 April.

Neulasta is a daily long-acting drug out of granulocyte colony-stimulating factor(G-CSF) drugs prescribed to decrease incidence of febrile neutropenia and period of febrile neutropenia for cancer patients who received cytotoxi...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.